| 摘要 |
<p>A method of reducing fat absorption in mammals includes orally administering to the mammals an effective amount of an inter-polymer complex formed between a polymeric glucosamine or its derivative and a polyacrylic acid or its derivative. The inter-polymeric composition can be in the form of a pharmaceutical composition that is capable of binding fat. The inter-polymer complex may be co-administering with one or more compounds selected from statins, IBAT inhibitors, MTP inhibitors, cholesterol absorption antagonists, phytosterols, stanols, CETP inhibitors, fibric acid derivatives, and antihypertensive agents.</p> |
